The clinical trial ecosystem is a complex web of investigator sites, laboratories, couriers, patient samples and more. The ability to track those samples though this ecosystem with full visibility for the sponsor is essential for a successful trial. In this episode, Barbara Nagaraj, Sr. IT Architect at BioFortis, a Q2 Solutions company, describes that ecosystem and the lifecycle of patient samples.
She describes:
- The varying approaches of small vs. large laboratories
- Risks of insufficient tracking
- Tracking consent for future use
- Current practice and opportunities for improved tracking
Learn more at https://www.q2labsolutions.com/labmatrix
The podcast Laboratory Considerations for Clinical Trials is embedded on this page from an open RSS feed. All files, descriptions, artwork and other metadata from the RSS-feed is the property of the podcast owner and not affiliated with or validated by Podplay.